Showing results (711-720 of 1,395) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|February 23, 2019
Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive DiseaseMatthew L Hemming, Kelly S Klega, Justin Rhoades, et al.
JCO Precision Oncology|September 19, 2019
Low Abundance of Circulating Tumor DNA in Localized Prostate CancerS Thomas Hennigan, Shana Y Trostel, Nicholas T Terrigino, et al.
JCO Precision Oncology|September 11, 2019
Acquired Resistance to Poly (ADP-ribose) Polymerase Inhibitor Olaparib in BRCA2-Associated Prostate Cancer Resulting From Biallelic BRCA2 Reversion Mutations Restores Both Germline and Somatic Loss-of-Function MutationsB A Carneiro, K A Collier, R J Nagy, et al.
JCO Precision Oncology|December 31, 2021
Evaluating Web-Based Direct-to-Consumer Genetic Tests for Cancer SusceptibilityMadison K Kilbride, Angela R Bradbury
JCO Precision Oncology|January 7, 2022
Revisiting Risk and Benefit in Early Oncology Trials in the Era of Precision Medicine: A Systematic Review and Meta-Analysis of Phase I Trials of Targeted Single-Agent Anticancer TherapiesMichael P Mackley, Nicholas R Fernandez, Benjamin Fletcher, et al.
JCO Precision Oncology|January 7, 2022
Biomarker Discovery and Outcomes for Comprehensive Cell-Free Circulating Tumor DNA Versus Standard-of-Care Tissue Testing in Advanced Non-Small-Cell Lung CancerRamon Palmero, Alvaro Taus, Santiago Viteri, et al.
JCO Precision Oncology|January 7, 2022
Insights for Quantifying the Long-Term Benefit of Immunotherapy Using Quantile RegressionBassirou Mboup, Christophe Le Tourneau, Aurélien Latouche
JCO Precision Oncology|January 7, 2022
Training, Validation, and Test of Deep Learning Models for Classification of Receptor Expressions in Breast Cancers From MammogramsDaiju Ueda, Akira Yamamoto, Tsutomu Takashima, et al.
JCO Precision Oncology|January 7, 2022
Impact of Variant Reclassification in Cancer Predisposition Genes on Clinical CareJianbang Chiang, Tze Hao Chia, Jeanette Yuen, et al.
JCO Precision Oncology|January 7, 2022
Plasma cfDNA Genotyping in Hospitalized Patients With Suspected Metastatic NSCLCMichael L Cheng, Marina S D Milan, Rubii M Tamen, et al.
Pageof 140